{"text_format":"2","workbook":"xlsx","n_sheets":2,"sheets":["工作表1","工作表2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"工作表1","index":0,"n_rows":47,"n_cols":84,"rows_kept":47,"cut":false,"hidden":false,"merged":[[5,0,5,6],[19,0,19,6],[20,0,20,6],[21,0,21,6],[14,0,14,1],[15,0,15,5],[16,0,16,4],[17,0,17,5],[10,0,10,5],[11,0,11,5],[12,0,12,5],[22,0,22,9],[26,0,26,7],[27,0,27,7],[7,0,7,7],[6,0,6,6],[24,0,24,6],[25,0,25,7],[28,0,28,6],[29,0,29,4],[30,0,30,4],[39,0,39,8],[31,0,31,4],[38,0,38,11],[37,0,37,10],[36,0,36,8],[35,0,35,8],[34,0,34,1]]}
["Case No.","Enrollment_Date (yyyy/mon)","Age (yr)","Sex (M/F)","Education ","身高(cm)","體重 (Kg)","Migraine history (Y/N)\n(ICD-10:G43)","有無使用避孕藥/OCP\n (Y/N)","有無tpa (Y/N)","有無IAT (Y/N)","Stroke_Type","NIHSS_Admission (0-42  Score)","mRS_3_Months (0-6 score)","TOAST_Classification","Brain_Imaging (CT/MRI) (Y/N)","Lesion_Side (L/R/Bilateral)","Hypertension (Y/N)\n(ICD10: I10-I13,I15)","Diabetes (Y/N)\n(ICD-10:E10-E14)\n參見註解7","Dyslipidemia (Y/N)\n(ICD-10:E78)","Atrial_Fibrillation (Y/N)\n(ICD-10:I 48)","Coronary_Artery_Disease (Y/N)\n(ICD-10:I 25)","Exercise_Frequency (days/week)","Sleep_Hours (hours)","抽菸 Smoking_Status","喝酒 Alcohol_Use","血壓 SBP (mmHg)","血壓 DBP (mmHg)","Wears_Device (Y/N)","Steps_Per_Day (Steps)","Heart_Rate_Resting (per minutes)","Recurrent_Stroke (Y/N)","Death (Y/N)","Cause_of_Death","PT (seconds)","APTT (seconds)","Red blood cell count (million/µL)","Hematocrit (%)","hemoglobin (g/L)","white blood cell count (/μL)","percentage of neutrophils among the white blood cells  (%)","percentage of monocytes among the white blood cells  (%)","percentage of eosinophils among the white blood cells  (%)","percentage of basophils among the white blood cells  (%)","percentage of lymphocytes among the white cells  (%)","platelet count (10^3/μL)","Glucose, AC (mg/dl)","HbA1c (%)","Albumin (g/L)","cholesterol (mg/dL)","Triglyceride (mg/dL)","HDL (mg/dL)","LDL (mg/dL)","Creatinine (mg/dL)","eGFR (mL/min/1.73m2)","hsCRP (mg/L)","APOE Genotype","ALDH2 rs671","MTHFR C677T","D-dimer (μg/ml)","Fibrinogen (mg/dL)","Uric acid (mg/dL)","Vitamin B12 (µg)","Folate (ng/mL) ","RF (IU/mL)","ESR (mm/hr)","AT Ⅲ: Function (%)","Protein C: Function (%)","Protein S: Function (%)","Lupus anticoagulant","RPR(Blood) (Non-reactive)","ANA (1:40為標準)","Anti-cardiolipin IgG (GPL-U/mL)","Homocysteine (μmol/L)","Anti-ß2-glycoprotein-I IgG (U/mL)","Anti-ß2-glycoprotein-I IgM (U/mL)","C-ANCA (Anti-PR3) (IU/ml )","P-ANCA (Anti-MPO) (IU/ml)","Anti-cardiolipin IgM (IU/mL)","Free T4 (ng/dL)","Anti-Thyroid Peroxidase Ab ( IU/mL)","3rd generation TSH (mIU/L)","Thyroglobulin Ab (IU/mL)","serum folate (ng/mL)"]
[]
[]
["註解:"]
["1. tPA"]
["• 全名：Tissue Plasminogen Activator"]
["• 中文：組織型纖溶酶原活化劑"]
["• 定義：急性缺血性中風患者於治療時間窗內所接受之靜脈血栓溶解治療"]
[]
["2. IAT"]
["• 全名：Intra-Arterial Thrombectomy"]
["• 中文：動脈內取栓治療（機械取栓）"]
["• 定義：針對中風治療的顱內動脈取栓術治療"]
[]
[" 3. NIHSS admission"]
["• 全名：National Institutes of Health Stroke Scale at admission"]
["• 中文：入院時 NIH 中風嚴重度評分"]
["• 定義：病人入院時之中風神經學功能缺損評估量表"]
[]
["4. TOAST classification"]
["• 全名：Trial of ORG 10172 in Acute Stroke Treatment classification"]
["• 中文：TOAST 缺血性中風病因分類"]
["• 定義：依據臨床表現、影像及相關檢查結果，將缺血性中風依病因分為不同亞型"]
[]
["5. mRS_3_Months"]
["• 全名：Modified Rankin Scale at 3 months"]
["• 中文：中風後三個月之改良雷氏量表"]
["• 定義：評估病人於中風後三個月之整體功能預後與失能程度"]
["• 單位：分數（score，0–6）"]
["0：無症狀"]
["1–2：輕度失能"]
["3–5：中度至重度失能"]
["6：死亡"]
[]
["6. MTHFR C677T"]
["全名：Methylenetetrahydrofolate Reductase gene C677T polymorphism"]
["中文：亞甲基四氫葉酸還原酶 C677T  多型性變異"]
["說明：MTHFR 基因負責編碼 methylenetetrahydrofolate reductase，此酶在葉酸（維生素 B9）代謝中扮演重要角色。"]
["C677T 為常見基因多型性，因 DNA 鹼基由 C 置換為 T，其中 TT 基因型者之酶活性降低最為明顯，可能導致同半胱胺酸（homocysteine）升高，並增加心腦血管疾病風險。"]
["不同基因型（CC, CT, TT）影響程度不同，通常與健康狀況的關聯性因人而異，需由醫生或遺傳諮詢師評估。 "]
[]
["7. ICD-10 for Diabetes"]
["E10:第一型糖尿病"]
["E11:第二型糖尿病"]
["E12:營養不良相關性糖尿病"]
["E13:其他特定糖尿病+伴隨併發症"]
["E14:未特指的糖尿病"]

{"sheet":"工作表2","index":1,"n_rows":16,"n_cols":12,"rows_kept":16,"cut":false,"hidden":true,"merged":[]}
["Education ","NIHSS_Admission (0-42  Score)","TOAST_Classification","Lesion_Side (L/R/Bilateral)","抽菸 Smoking_Status","APOE Genotype","ALDH2 rs671","Lupus anticoagulant","Anti-cardiolipin IgG (GPL-U/mL)","Stroke_Type","喝酒 Alcohol_Use","MTHFR C677T"]
["1.小學","意識程度 (1a)                       0-3","1.大血管粥樣硬化（栓塞/血栓）","L","1.Current","1.E2/E2","1.G/G","0.LA is negative  (or LA1/LA2=1.0 or LA is not detected)","1.Negative：＜10 GPL-U/mL","1.Ischemic","1.Never","1.CC"]
["2.國中","意識程度 (1b)                       0-2","2.心源性栓塞（高危險/中度危險）","R","2.Former","2.E3/E3","2.A/G","1.LA1/LA2=1.2~1.5(LA is weakly present) ","2.Weak positive：10-40 GPL-U/mL","2.Hemorrhagic","2.Social drinking","2.CT"]
["3.高中","意識程度 (1c)                       0-2","3.小血管阻塞（小洞中風）","Bilateral","3.Never","3.E4/E4","3.A/A","2.LA1/LA2=1.5~2.0(LA is moderately present) ","3.Positive：＞40 GPL-U/mL",null,"3.Alcoholism (酗酒): male >30 gm/day,","3.TT"]
["4.大學","眼球運動 (2)                         0-2","4.其他原因之中風",null,null,"4.E2/E3",null,"3.LA1/LA2≧2.0(LA is stronly present) ",null,null,"    female>25 gm/day, 大約是每天一罐啤酒的量"]
["5.研究所","視野 (3)                                 0-3","5.原因未明之中風",null,null,"5.E2/E4",null,"4.LA is positive",null,null,"4.Former(已戒酒)"]
[null,"面部肌力 (4)                        0-3","    a具二個（含）以上之中風原因",null,null,"6.E3/E4"]
[null,"上肢運動 (5aL, 左上肢)    0-4","    b.檢查無發現"]
[null,"上肢運動 (5bR, 右上肢)   0-4","    c.檢查不完全"]
[null,"下肢運動 (6aL, 左下肢)    0-4"]
[null,"下肢運動 (6bR, 右下肢)   0-4"]
[null,"肢體運動失調 (7)               0-2"]
[null,"感覺功能 (8)                        0-2"]
[null,"語言功能 (9)                        0-3"]
[null,"構音困難 (10)                     0-2"]
[null,"忽略 (11)                              0-2"]